Investmark Advisory Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Investmark Advisory Group's IBB Position: Q3 2026 in Review
Investmark Advisory Group reduced its iShares Biotechnology ETF (IBB) stake by 0.04% in Q3 2026, selling an estimated $201 and leaving 2,596 shares worth $547K. The position accounts for 0.18% of the portfolio, ranked #92.
Investmark Advisory Group first reported a position in IBB in Q4 2021 and has held it in 20 quarters since. 1,029 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- Investmark Advisory Group held 2,596 shares of iShares Biotechnology ETF worth $547K as of Q3 2026.
- Investmark Advisory Group sold 1 iShares Biotechnology ETF share in Q3 2026, an estimated $201.
- iShares Biotechnology ETF made up 0.18% of Investmark Advisory Group's portfolio in Q3 2026, its #92 holding.
- Investmark Advisory Group first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 20 quarters since.
- 1,029 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on Investmark Advisory Group's 13F filing for Q3 2026, filed 27 Oct 2026.